Literature DB >> 30185477

Early Peritoneal Dialysis Technique Failure: Review.

Yeoungjee Cho1,2, Emily J See3, Htay Htay4, Carmel M Hawley5,2, David W Johnson5,2,6.   

Abstract

There is a growing, global burden of patients with end-stage kidney disease (ESKD) requiring renal replacement therapy. Although peritoneal dialysis (PD) is considered to be the most cost-effective dialysis modality, its utilization has been declining in some regions. The first year after starting PD is thought to be a vulnerable period for technique failure, which in turn contributes to poor patient retention. Improved understanding of the risk factors for technique failure during this period may help the development of targeted strategies to lower its incidence and improve both the utilization and utility of PD. This up-to-date review will summarize current evidence regarding the definition, incidence, causes, and predictors of early PD technique failure. Promising avenues for directing future research efforts will also be discussed.
Copyright © 2018 International Society for Peritoneal Dialysis.

Entities:  

Keywords:  ESKD; end-stage kidney disease; predictors; retention

Mesh:

Year:  2018        PMID: 30185477     DOI: 10.3747/pdi.2018.00017

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  3 in total

Review 1.  Why Peritoneal Dialysis is Underutilized in the United States: A Review of Inequities.

Authors:  Juri Bassuner; Bridget Kowalczyk; Ahmed Kamel Abdel-Aal
Journal:  Semin Intervent Radiol       Date:  2022-02-18       Impact factor: 1.513

2.  Home Hemodialysis and Peritoneal Dialysis Patient and Technique Survival in Canada.

Authors:  Annie-Claire Nadeau-Fredette; Karthik K Tennankore; Jeffrey Perl; Joanne M Bargman; David W Johnson; Christopher T Chan
Journal:  Kidney Int Rep       Date:  2020-08-26

3.  Incidence and Risk Factors Associated with Technique Failure in the First Year of Peritoneal Dialysis: A Single Center Retrospective Cohort Study in Southern China.

Authors:  Xiao Dong; Haishan Wu; Hongjian Ye; Chunyan Yi; Xiangwen Diao; Ruihua Liu; Haiping Mao; Fengxian Huang; Xueqing Yu; Xiao Yang
Journal:  BMC Nephrol       Date:  2022-06-11       Impact factor: 2.585

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.